Table 4.
Categorical predictors of symptoms and function
| Predictor | x̄ (SD) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex | HbA1c <7.0 at baseline | Cancer Mets | Insulin | Diabetes <5 years | Diabetes <10 years | Comorbidity | |||||||||
| Female | Male | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | 0-1 | 2-4 | ≥5 | |
| Total symptom severity | |||||||||||||||
| Baseline | 62 (23) | 36 (20) | 49 (20) | 46 (26) | 47 (18) | 47 (37) | 49 (33) | 51 (24) | 59 (21) | 47 (27) | 55 (22) | 46 (29) | 44 (28) | 50 (30) | 55 (22) |
| 12 weeks | 49 (31) | 45 (36) | 62 (31) | 32 (27) | 40 (NA) | 40 (30) | 50 (35) | 46 (33) | 39 (32) | 51 (33) | 43 (36) | 50 (30) | 50 (36) | 17 (5) | 56 (30) |
| Total symptom interference | |||||||||||||||
| Baseline | 54 (25) | 21 (17) | 35 (20) | 36 (25) | 35 (18) | 40 (30) | 47 (36) | 36 (24) | 50 (22) | 35 (28) | 43 (21) | 35 (32) | 33 (25) | 42 (33) | 41 (26) |
| 12 weeks | 39 (34) | 27 (23) | 41 (24) | 24 (32) | 17 (NA) | 34 (29) | 49 (37) | 27 (25) | 24 (29) | 37 (29) | 29 (28) | 36 (31) | 32 (31) | 15 (1) | 40 (31) |
| Physical function | |||||||||||||||
| Baseline | 28 (7) | 32 (4) | 30 (6) | 31 (6) | 32 (4) | 29 (7) | 28 (7) | 30 (6) | 28 (7) | 31 (6) | 29 (6) | 31 (6) | 30 (5) | 30 (7) | 29 (7) |
| 12 weeks | 28 (7) | 35 (9) | 30 (9) | 33 (9) | 26 (NA) | 32 (9) | 28 (4) | 32 (10) | 27 (9) | 33 (8) | 28 (7) | 34 (10) | 34 (12) | 27 (2) | 30 (7) |
| Mental function | |||||||||||||||
| Baseline | 46 (10) | 55 (7) | 52 (9) | 49 (11) | 50 (7) | 50 (11) | 46 (12) | 51 (9) | 53 (8) | 49 (11) | 51 (10) | 49 (11) | 56 (8) | 52 (8) | 44 (10) |
| 12 weeks | 50 (12) | 53 (8) | 52 (8) | 51 (13) | 50 (NA) | 52 (11) | 44 (14) | 54 (8) | 56 (7) | 49 (11) | 53 (7) | 49 (13) | 55 (9) | 58 (7) | 45 (10) |
Corresponding samples sizes for each grouping are shown in Table 1. NA: SD could not be calculated based on sample size of 1, HbA1c: Glycated hemoglobin, SD: Standard deviation